Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.03
+0.10 (1.44%)
At close: Mar 18, 2026, 4:00 PM EDT
7.04
+0.01 (0.14%)
After-hours: Mar 18, 2026, 7:18 PM EDT
Precision BioSciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Precision BioSciences stock has a target of 60, which predicts a 753.49% increase from the current stock price of 7.03.
Price Target: $60 (+753.49%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 21, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Precision BioSciences is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +753.49% | May 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +753.49% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +753.49% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +753.49% | Feb 19, 2025 |
| BMO Capital | BMO Capital | Hold → Buy Upgrades $34 | Hold → Buy | Upgrades | $34 | +383.64% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
12.52M
from 34.26M
Decreased by -63.46%
Revenue Next Year
18.59M
from 12.52M
Increased by 48.47%
EPS This Year
-2.91
from -3.56
EPS Next Year
-2.85
from -2.91
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 33.0M | 47.9M | |||
| Avg | 12.5M | 18.6M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -3.8% | 282.4% | |||
| Avg | -63.5% | 48.5% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.05 | -1.32 | |||
| Avg | -2.91 | -2.85 | |||
| Low | -5.11 | -3.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.